Ledipasvir and Sofosbuvir for Recurrent Hepatitis C After Liver Transplantation

BioScience Trends - Japan
doi 10.5582/bst.2016.01223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Related search

Sofosbuvir Plus Ledipasvir for Recurrent Hepatitis C in Liver Transplant Recipients

Liver Transplantation
HepatologyTransplantationSurgery
2017English

The Use of Sofosbuvir for the Treatment of Recurrent Hepatitis C After Liver Transplantation

Transplantologiya
2017English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

NS5A-P32 Deletion After Failure of Ledipasvir/Sofosbuvir in Hepatitis C Virus Genotype 1b Infection

Hepatology
MedicineHepatology
2018English

Hepatitis C Virus Recurrence After Liver Transplantation

Gut
Gastroenterology
1999English

Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population

Digestive Diseases and Sciences
PhysiologyGastroenterology
2018English

New and Evolving Management Paradigms for Hepatitis C After Liver Transplantation

Current Hepatitis Reports
2011English

Hepatitis C and Liver Transplantation

2012English

Recurrent Hepatitis C Virus (Genotype 4) Infection After Living Donor Liver Transplantation: Risk Factors and Outcome

Journal of Liver
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy